Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism 5-HT2A receptor agonists(Serotonin 2a (5-HT2a) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H16FN |
InChIKeyCEBKSYZFDRGTPH-UHFFFAOYSA-N |
CAS Registry3088416-13-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Central Nervous System Diseases | Preclinical | United States | 09 Jul 2025 | |
| Psychotic Disorders | Preclinical | United States | 09 Jul 2025 |





